Comorbidity Control Might Slow MS Activity
COPENHAGEN — The largest and perhaps most rigorous study to demonstrate an association between the presence of comorbidities and accelerated progression of multiple sclerosis (MS) is sufficiently compelling that both the study author and an independent …